_edited_edited_.png){kind=logo}
About
Toxicity analysis services evaluate the potential harmful effects of chemical compounds, drugs, or natural products on biological systems. Using computational tools and in vitro/in vivo data, we assess parameters such as mutagenicity, carcinogenicity, hepatotoxicity, cardiotoxicity, and general cytotoxicity. This helps predict safety profiles early in the drug development process, reduce experimental costs, and guide compound optimization. Our analyses include ADMET (absorption, distribution, metabolism, excretion, and toxicity) predictions, supported by reliable databases and software like SwissADME, ProTox-II, and pkCSM, providing a comprehensive safety evaluation.
Toxicity Analysis –
Safety Prediction: Evaluate mutagenicity, carcinogenicity, hepatotoxicity, cardiotoxicity, and cytotoxicity.
In Silico Tools: Use of SwissADME, ProTox-II, pkCSM, and other computational platforms.
ADMET Profiling: Assessment of absorption, distribution, metabolism, excretion, and toxicity.
Early Screening: Identify potential toxic effects to guide safer drug design.
Risk Reduction: Minimize late-stage failures and reduce reliance on animal testing.
Data Integration: Combine computational predictions with experimental data where available.
Comprehensive Reports: Detailed toxicity profiles to support decision-making in R&D.